Press Release
Marlin portfolio company Radar Healthcare acquires Cemplicity
LOS ANGELES and LONDON, August 12, 2026 – Marlin Equity Partners (“Marlin”) is pleased to announce that it has acquired Cemplicity, a patient experience and patient-reported outcomes platform. Cemplicity will be merged with Radar Healthcare, an existing Marlin portfolio company and a provider of risk, quality and compliance software for the healthcare and social care sectors, further strengthening its position in the market. Cemplicity adds established capabilities in patient-reported experience measures (“PREMs”), patient-reported outcome measures (“PROMs”), real-time patient feedback, shared decision-making insights, surgical site inspection surveillance, service recovery feedback and post-care outcomes.
This transaction builds on Radar Healthcare’s recent acquisition of EIDO Healthcare, a provider of digital consent and patient information solutions, further expanding Radar Healthcare’s ability to support healthcare organizations across quality, safety, patient engagement, informed consent and measurable improvement. It also extends Radar Healthcare's international footprint through Cemplicity's established operations across Australia and New Zealand (“ANZ”), creating a platform for growth in the ANZ market for Radar Healthcare, while expanding the combined presence in the Middle East and the United Kingdom.
Together, Radar Healthcare and Cemplicity will help healthcare organizations connect the patient voice, patient experience and outcomes with the governance and improvement workflows needed to identify risks earlier, intervene sooner, reduce avoidable harm and continuously improve patient outcomes through evidence-based action.
"Radar Healthcare and Cemplicity share a clear purpose: helping healthcare organizations improve quality, deliver safer care, enhance patient experiences and achieve better outcomes,” said Edward Bellamy, Chief Executive Officer of Radar Healthcare. “Cemplicity brings deep expertise in patient experience, patient-reported outcomes and real-time patient insight, which strongly complements Radar Healthcare’s quality, risk, compliance and improvement platform. Together, we can help customers connect what patients are experiencing with the workflows needed to act on that insight and drive meaningful improvement.”
“Cemplicity has always focused on helping healthcare teams understand experience and outcomes from the patient perspective,” said Blaik Wilson, Chief Executive Officer of Cemplicity. “Joining Radar Healthcare gives us an exciting opportunity to build on that work, extend our impact and support more organizations in using patient-reported insight to improve care. We look forward to working with the Radar Healthcare team on this next chapter.”
About Marlin Equity Partners
Marlin Equity Partners is a global investment firm with nearly $10 billion in capital commitments specializing in the software, technology and services sectors. Marlin’s mission is to partner with exceptional management teams to drive scale and enhance long-term value in businesses through its deep domain expertise, extensive network and operational transformations focused on product innovation, go-to-market enhancements, and strategic M&A. Founded in 2005, Marlin has completed over 270 acquisitions. The firm is headquartered in Los Angeles, California, with an additional office in London. For more information, please visit www.marlinequity.com.
About Radar Healthcare
Radar Healthcare empowers health and social care organizations to make a meaningful impact on patient safety, quality of care and compliance. By blending digital innovation with real-world healthcare expertise, Radar Healthcare enables providers to not only meet regulatory standards but to actively spot trends, prevent incidents, and drive continuous improvement. Designed with flexibility and adaptability in mind, and with a deep understanding of the daily challenges in health and care, Radar Healthcare is dedicated to evolving alongside the industry, delivering a system that is valued for its role in shaping safer, more effective care. For more information, please visit www.radarhealthcare.com.
Contact:
Peter Spasov
(310) 364-0100
pspasov@marlinequity.com